ClinVar Miner

Submissions for variant NM_001367721.1(CASK):c.2175T>C (p.Leu725=)

gnomAD frequency: 0.00009  dbSNP: rs757563548
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000553027 SCV000647907 benign Intellectual disability, CASK-related, X-linked 2023-11-13 criteria provided, single submitter clinical testing
Ambry Genetics RCV002316566 SCV000851608 likely benign Inborn genetic diseases 2017-03-20 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
GeneDx RCV001584309 SCV001811794 likely benign not provided 2019-12-04 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004538030 SCV004737142 likely benign CASK-related disorder 2020-02-24 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.